Johnson & Johnson to pay $5.5 billion to settle talc-related cancer claims

Business Standard Business Standard

The agreement requires the participation of lead plaintiff firms in ovarian talc litigation pending in state and federal courts that represent at least 95% of claims

Read full article at Business Standard →